SANTA ROSA, CA--(Marketwire -06/19/12)- Following a recent business trip to China, Andrew Schneider, CEO of Rotoblock Corp. (RTBC), said there is a critical need for non-incinerator-based medical waste treatment.
Appointed as CEO in January, Schneider traveled to China for several weeks to meet with various parties from Rotoblock's 2011 acquisition of controlling interest in daifuWaste Holdings, a provider of non-incinerator medical waste treatment systems in China. This treatment alternative shreds, compacts and treats medical waste with high pressure, heat and steam before it is moved to landfill. China has established aggressive goals to cut pollution and improve medical waste treatment.
"This was my first trip to China and the skies in the cities are constantly gray due to air pollution," said Schneider, "so immediately you can see the need for our non-incinerator-based systems."
Schneider noted that the old incinerator systems installed to address medical waste have instead become an environmental problem as they wear down over several years of operation, releasing soot, smoke and toxic fumes. With more than 17,000 hospitals throughout China, Schneider says Rotoblock can fill an urgent need for China.
"Not only has China tested these non-incinerator systems," said Schneider, "I learned recently Rotoblock's medical waste treatment has all the features and specifications that satisfy the most recent government requirements for environmental improvements and the transition to an non-incinerating era."
Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.